Rapid Sterility Testing
Pharmaceutical Quality Control (503A Compounding)
ValidationActive
Key Facts
Indication
Pharmaceutical Quality Control (503A Compounding)
Phase
Validation
Status
Active
Company
About Aequita Bioworks
Founded in 2021 and based in Cambridge, USA, Aequita Bioworks is a private, pre-revenue biotech company with a dual focus on diagnostics and therapeutics. Its core offering is a proprietary, automated platform that accelerates critical quality control assays, beginning with rapid sterility testing for the compounding pharmacy market. Led by a team with backgrounds in AI, biotech research, and operations, the company is leveraging its platform to develop additional assay products and a novel biologic aimed at mitigating muscle loss during GLP-1 weight loss therapy.
View full company profile